CA1278748C - Compose pharmaceutique pour le traitement associe des cancers hormonodependants - Google Patents

Compose pharmaceutique pour le traitement associe des cancers hormonodependants

Info

Publication number
CA1278748C
CA1278748C CA000488048A CA488048A CA1278748C CA 1278748 C CA1278748 C CA 1278748C CA 000488048 A CA000488048 A CA 000488048A CA 488048 A CA488048 A CA 488048A CA 1278748 C CA1278748 C CA 1278748C
Authority
CA
Canada
Prior art keywords
cancer
sex steroid
antiandrogen
inhibitor
antiestrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000488048A
Other languages
English (en)
Inventor
Fernand Labrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/699,711 external-priority patent/US4659695A/en
Priority claimed from US06/699,702 external-priority patent/US4666885A/en
Priority claimed from US06/699,710 external-priority patent/US5023234A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1278748C publication Critical patent/CA1278748C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000488048A 1985-02-08 1985-08-02 Compose pharmaceutique pour le traitement associe des cancers hormonodependants Expired - Lifetime CA1278748C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US699,702 1976-06-25
US06/699,711 US4659695A (en) 1985-02-08 1985-02-08 Method of treatment of prostate cancer
US699,711 1985-02-08
US06/699,702 US4666885A (en) 1985-02-08 1985-02-08 Combination therapy for treatment of female breast cancer
US699,710 1985-02-08
US06/699,710 US5023234A (en) 1985-02-08 1985-02-08 Combination male breast cancer therapy

Publications (1)

Publication Number Publication Date
CA1278748C true CA1278748C (fr) 1991-01-08

Family

ID=27418692

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000488048A Expired - Lifetime CA1278748C (fr) 1985-02-08 1985-08-02 Compose pharmaceutique pour le traitement associe des cancers hormonodependants

Country Status (1)

Country Link
CA (1) CA1278748C (fr)

Similar Documents

Publication Publication Date Title
CA1278515C (fr) Compose pharmaceutique pour le traitement associe des cancers hormonodependants
EP0195015B1 (fr) Composition pharmaceutique pour le traitement de cancers dependant d'hormones
US4760053A (en) Combination therapy for selected sex steroid dependent cancers
US4666885A (en) Combination therapy for treatment of female breast cancer
US4659695A (en) Method of treatment of prostate cancer
US5550107A (en) Combination therapy for the treatment of estrogen-sensitive disease
EP0943328B1 (fr) Thérapie combinée dans la prophylaxe et/ou dans le traitement de l'hyperplasie benigne de la prostate
US6423698B1 (en) Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
EP0595796B1 (fr) Procede de traitement des maladies associees aux androgenes
US4895715A (en) Method of treating gynecomastia
JP6532754B2 (ja) エストロゲン関連疾患を治療するまたは予防するための方法
US5023234A (en) Combination male breast cancer therapy
US5064813A (en) Combination therapy for selected sex steroid dependent cancers
CA1278748C (fr) Compose pharmaceutique pour le traitement associe des cancers hormonodependants
US20120004182A1 (en) Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
AU2001296578A1 (en) Combination therapy for the treatment of estrogen-sensitive disease
Foldesy et al. Role of adrenal androgens in prostate regression in rats treated with an antiandrogen and an LHRH agonist

Legal Events

Date Code Title Description
MKEX Expiry